De Dietrich joins PIPAC consortium to develop continuous API manufacturing platform
BRKR•PIPAC consortium expands with De Dietrich
De Dietrich joined the PIPAC consortium with Alysophil, Bruker and Novalix to validate a continuous API manufacturing platform.
The pilot program has been completed, combining continuous-flow chemistry with AI-driven real-time analytics, monitoring and control to replace batch production.
Supply-chain resilience and reshoring focus
The project targets supply-chain resilience, supporting efforts to reshore API production amid recent disruptions, geopolitical uncertainty and capacity concentration.
Platform validated with continuous-flow fentanyl production
The platform was validated through continuous-flow production of fentanyl, a highly regulated API, supporting potential expansion to other pharmaceutical ingredients.
